whatshot

PRVB   $24.98  3.18% Market Closed

Provention Bio Inc
show_chart Advanced Chart of PRVB
Last Events:

2023-04-28 Trend pattern changed from расходящийся треугольник to восходящий треугольник.

2023-04-28 Signal in Stochastic changed from bullish recovery to bullish. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: main and signal line crossing.

2023-04-28 Signal in MACD changed from bullish weakening to bearish reversal. Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: exit from the overbought zone.

2023-04-28 Trend Power changed from to slow.

2023-04-28 Trend changed from flat and up to up and flat.

2023-03-30 Trend pattern changed from расходящийся клин с наклоном вверх to расходящийся треугольник.

2023-03-30 Signal in Stochastic changed from bearish reversal to bullish recovery. The stochastic indicator is in overbought territory and it grows. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

2023-03-30 Signal in MACD changed from bullish to bullish weakening. Oscillator MACD is in the positive territory it's higher than the signal line and falls. These factors mean that the growing trend persists, but the growth rate is declining. Last signal: signal line crossed the middle level.

Current temperature: 0.39
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 12.52
Target: 24.00
High with 50% probability: 37.23
Analyst Recommendations:
Number of estimates 6
Target Price Mean 24.00
Mean unverified/preliminary 24.00 / 24.00
Target Price Low / High 19.00 / 25.00
Median / STD DEV 25.00 / 2.45
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy ActivelyBuy -
rsi Sell Buy -
macd Sell - -
stoch - - -
ma20 ActivelyBuy ActivelyBuy -
ma50 Sell - -
ma100 Buy ActivelyBuy -
Candlestick PatternApril 26, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US74374N1028
ceo Mr. Ashleigh W. Palmer B.Sc., M.B.A.
Website https://www.proventionbio.com
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China. Provention Bio, Inc. was incorporated in 2016 and is headquartered in Red Bank, New Jersey.